InvestSMART

Control Bionics Limited (ASX: CBL) - Announcements

- Current share price for CBL : $0.060

ASX company news and announcements for Control Bionics Limited (CBL) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Control Bionics Limited (CBL) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Control Bionics Limited (CBL), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Control Bionics Limited (CBL)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$33 Proposed issue of securities - CBL 14 May 2026 4:20PM $0.065 $0.060 fallen by 7.69%
$33 Initial Director's Interest Notice - Opie 14 May 2026 4:10PM $0.065 $0.060 fallen by 7.69%
$33 Final Director's Interest Notice - Phillips 14 May 2026 4:09PM $0.065 $0.060 fallen by 7.69%
$33 Leading neurotechnology pioneer Prof Nicholas Opie joins CBL 14 May 2026 8:19AM $0.063 $0.060 fallen by 4.76%
$33 Control Bionics Strategic Transition Presentation 5 May 2026 8:10AM $0.056 $0.060 risen by 7.14%
$33 Quarterly Activities/Appendix 4C Cash Flow Report 30 Apr 2026 8:41AM $0.055 $0.060 risen by 9.09%
$33 First U.S. Letter of Intent for iOS Speech Device Program 26 Mar 2026 8:21AM $0.058 $0.060 risen by 3.45%
$33 German Statutory Reimbursement Listing for NeuroNode 4 Mar 2026 8:20AM $0.055 $0.060 risen by 9.09%
$33 Change of Director's Interest Notice - Rix 2 Mar 2026 3:20PM $0.059 $0.060 risen by 1.69%
$33 Investor call presentation 26 Feb 2026 8:32AM $0.060 $0.060 fallen by 0%
$33 Joint venture with NextLevel Assistive Technology 26 Feb 2026 8:24AM $0.060 $0.060 fallen by 0%
$33 Half Yearly Report and Accounts 26 Feb 2026 8:23AM $0.060 $0.060 fallen by 0%
$33 Investor Briefing 25 Feb 2026 6:33PM $0.060 $0.060 fallen by 0%
$33 PRC-Saltillo - Distribution Agreement 29 Jan 2026 9:27AM $0.057 $0.060 risen by 5.26%
$33 Quarterly Activities/Appendix 4C Cash Flow Report 28 Jan 2026 8:27AM $0.067 $0.060 fallen by 10.45%
$33 Tobii Dynavox - Distribution Partnership 27 Jan 2026 8:23AM $0.069 $0.060 fallen by 13.04%
$33 Cleansing notice 2 Jan 2026 8:35AM $0.061 $0.060 fallen by 1.64%
$33 Application for quotation of securities - CBL 2 Jan 2026 8:35AM $0.061 $0.060 fallen by 1.64%
$33 Proposed issue of securities - CBL 31 Dec 2025 10:10AM $0.062 $0.060 fallen by 3.23%
$33 CBL Completes Acquisition of Neuro Elite Athletics 31 Dec 2025 10:09AM $0.062 $0.060 fallen by 3.23%
$33 Becoming a substantial holder - Reitham 8 Dec 2025 6:08PM $0.074 $0.060 fallen by 18.92%
$33 Cleansing Notice 8 Dec 2025 5:33PM $0.074 $0.060 fallen by 18.92%
$33 Application for quotation of securities - CBL 8 Dec 2025 5:32PM $0.074 $0.060 fallen by 18.92%
$33 Acquisition of Full Ownership of Neuro Elite Athletics 3 Dec 2025 8:38AM $0.079 $0.060 fallen by 24.05%
$33 Notification regarding unquoted securities - CBL 1 Dec 2025 5:19PM $0.069 $0.060 fallen by 13.04%

51 - 75 of 626 results

Page 3 of 26

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.